Insider · CIK 0001485417
James Samuel Shannon
Files at MNKD (MANNKIND CORP), XLO (Xilio Therapeutics, Inc.). First filing Jun 18, 2025, latest Jun 18, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XLO: Xilio Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | Xilio Therapeutics, Inc. | $48k 70,000 shares | - | +6% from low-54% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | XLO Xilio Therapeutics, Inc. | POpen-market purchase Common Stock | +45,000 | $0.69 | $31k | 45,000 | Jun 18, 2025 |
| Jun 17, 2025 | XLO Xilio Therapeutics, Inc. | POpen-market purchase Common Stock | +25,000 | $0.69 | $17k | 70,000 | Jun 18, 2025 |
| Jun 11, 2025 | XLO Xilio Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Jun 12, 2025 |
| May 14, 2025 | MNKD MANNKIND CORP | AGrant or award Restricted Stock Unitderivative | +52,854 | $0.00 | $0 | 52,854 | May 16, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.